Apic Bio, Inc. develops and leverages a gene therapy platform to treat rare diseases with complex mechanisms. The company develops gene therapy for treatment of alpha-1 antitrypsin deficiency.

Apic Bio
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.apic-bio.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address26 Kevin Road, MA 01890WinchesterUnited States
26 Kevin Road, MA 01890
Winchester
United States
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/apic-bio-inc” connections=”true” suffix=””]